SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a intense regulatory dispute with the FDA ahead of an upcoming advisory committee meeting, where the company and agency are clashing over which Statistical Analysis Plan (SAP) should govern the HOPE-3 trial results. Investors are actively debating whether Capricor's defense against claims of post-hoc data manipulation will succeed, with community sentiment split between those viewing the FDA's briefing as evidence of incompetence or bias and those concerned that the statistical foundation of the trial results is fundamentally fragile.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is surging following a strong quarterly earnings report that featured a revenue beat and upwardly revised guidance, fueled by accelerating demand for AI server infrastructure and networking hardware. Community sentiment remains highly bullish, with many investors viewing the company as a key beneficiary of hyperscaler capital expenditures and expressing confidence in its long-term growth trajectory within the AI data center ecosystem.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing selling pressure as investors scrutinize the company's role in potentially financing massive AI data center projects, raising concerns about circular financing and heightened credit risk. The community remains deeply divided, with some investors viewing the pullback as a strategic buying opportunity amid firm demand, while bears point to rising competition and balance-sheet exposure as signs of an overextended AI market.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors react to a significant pullback in share price following the announcement of a large secondary stock offering by the Kim family. While some market participants are wary of the increased float and downward pressure, others view the temporary dip as an attractive entry point, noting that the move is non-dilutive and does not impact the company's strong fundamentals within the AI infrastructure and advanced packaging supply chain.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is trending due to the approval of a significant 2026 global restructuring plan, which involves substantial cost-cutting measures and organizational changes meant to reinvest in growth initiatives. Community discussions are heavily focused on how these restructuring expenses will impact short-term earnings and the stock's potential to reverse its recent downward price trend heading into the upcoming quarterly report.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing heightened volatility and selling pressure as the market weighs a recent permit rejection for a critical data center project against the stock's strong, long-term AI infrastructure thesis. The community is sharply divided, with bulls viewing the pullback as an attractive accumulation opportunity ahead of upcoming earnings, while bears point to valuation concerns and regulatory hurdles as signals of further downside.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies (BMNR) is trending as investors react to the company's shift toward stock buybacks, with community discussions intensifying over the company's massive Ethereum treasury and the potential impact of the stalled Clarity Act. While some market participants remain skeptical of the stock's performance and management's capital allocation, others are focusing on the deep discount to net asset value as a potential entry point for long-term holders.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy (FLNC) is trending as investors weigh significant backlog growth and strategic AI data center partnerships against recent insider selling activity and broader market volatility. The community remains focused on the company's ability to convert hyperscaler deals into consistent profitability, while technical analysts continue to monitor key support levels amid ongoing price swings.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing intense community speculation as investors anticipate imminent Phase 3 IZAR-1 trial results, with many actively positioning ahead of the upcoming BTIG conference. The discourse is dominated by debates over potential M&A activity, the company's trial design efficacy, and whether management will release clinical data during a standalone event or bundle it with earnings.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense community debate as investors weigh strong earnings and massive buybacks against concerns that generative AI tools may disrupt its core creative software business. While some traders are betting on a recovery driven by its dominance in enterprise workflows, others are aggressively shorting the stock, citing analyst downgrades and fears that it will be displaced by newer, AI-native competitors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

twitter

Neutral Sentiment

No one knows

Last day it will flush to red

Bitcoin is green in July after starting the month around $61,900, but the market still faces its biggest catalyst of the month: the Fed's July 28-29 rate decision. Will crypto end the month in the green? Vote and explain your reasoning in the comments.

July ends on Friday. Will crypto end the month in the green?

Feed

News

Sentiment

Info

Historical Prices

GFSONGlobalFoundries (Ondo Tokenized)

Fundamentals

Latest GFSON News